INTRODUCTION
Nearly one-fifth of Medicare beneficiaries are readmitted within 30 days [1] . The Centers for Medicare and Medicaid Services (CMS) estimates that readmissions cost Medicare $26 billion annually, of which $17 billion is potentially avoidable [1] . On 1 October 2012, mandated by Section 3025 of the Affordable Care Act to establish the Medicare Hospital Readmissions Reduction Program (HRRP), the Centers for Medicare and Medicaid Services (CMS) implemented a strategy of linking quality to payment that relies on financial penalties to improve inpatient care quality and reduce cost [2] . CMS measures a hospital's excess readmission ratio by comparing its readmission performance to the national average, adjusted for patients' clinical risk factors at the time of the index admission [3] . The Medicare Payment Advisory Commission identified congestive heart failure (CHF), acute myocardial infarction (AMI) and pneumonia as common, costly, and potentially preventable causes of readmission, and suggested that Congress and CMS should implement policies address these high readmission rates [4] . Therefore, these three conditions were selected as targets for which hospitals with excessive all-cause rehospitalization within 30 days of discharge were penalized by CMS [5] . This policy has increased the interest in investigating more evidence and attributes of rehospitalizations.
Numerous studies were conducted on rehospitalizations, most of which focused on patientlevel risk factors with various clinical conditions [6] [7] [8] [9] [10] [11] . However, most of them of lump same-hospital and different-hospital readmission together and ignore the fact the differenthospital readmission may be triggered by different clinical and social circumstance [12] [13] [14] .
Different-hospital readmissions constitute 18-29% of overall readmissions [3] . These different-hospital readmissions brought higher costs (median additional $ 1308 per person) to the patients readmitted in a different hospital than those who readmitted to the index hospital [15] . Further, readmission to a different hospital may contribute to a lack of continuity of clinical information regarding treatment decisions, leading to delayed medical decision making, duplicated diagnostic tests or treatments, and poorer outcomes [16, 17] . Moreover, among readmitted surgical patients, those returning to the index hospital where their surgery took place can achieve improved survival. However, existing literature does not present the breadth of different hospital readmission pattern as it has been restricted to specific conditions, a small number of hospitals, and the Medicare population [3] . There is no investigation regarding the patterns and determinants of nonindex hospital readmissions within the Medicare and non-Medicare population. A better understanding of the patterns and determinants of different-hospital readmissions could shed light on opportunities for improving care quality for patients.
Another important issue is the disparity in rates of medical/surgical readmission for patients with serious mental illness (SMI) compared to patients without SMI. In 2016, there were an estimated 18.3% of the U.S. adults suffering mental illness, and there were 4.2% of all adults in U.S have more serious mental illness. Among adults with mental disorders, around 68% have comorbid medical conditions [18] . After a general hospital stay, patients with SMI may fail to have proper follow-up medical treatment and self-care, which increases their risk for rehospitalization [19] .
There is a growing body of literature examining the relationship between SMI and medical/surgical readmissions. Prior studies found SMI comorbidity among patients with cardiovascular disease, pneumonia, diabetes and chronic kidney disease is associated with increased risk of 30-readmissions and beyond [5, [20] [21] [22] . Many studies presented results of multivariate analysis of the relationship between SMI and 30-day readmission controlling for potentially confounding demographic and clinical conditions. Most of them found the odds of patients with SMI readmitting were significantly higher than for those without SMI [22] [23] [24] [25] [26] [27] . In a study of readmissions among medical/surgical patients, medical patients with comorbid SMI had higher odds of rehospitalization at 7, 30, 60, 90 and 180 days compared to those without a comorbid SMI diagnosis, but among surgical inpatients with SMI, there was no difference in readmission [28] . This existing research was restricted to a limited scope of hospitals, and ought to be expanded to a national examination.
In this study, we had two aims to better understand readmissions. In the first aim, we used a statewide hospital discharge database to examine non-index readmissions. We examined index admissions for CHF, AMI, and Pneumonia-the three leading causes of readmissions [29] [30] [31] . We investigated the change of readmission rate for each cohort over different readmission intervals through 5 years. We compared patterns of non-index readmissions for Medicare and non-Medicare populations over time from 2010 to 2014.
We also examined predictors of non-index readmissions to better understand what factors underlie different hospital destinations for patients' readmissions. In the second aim, we examined the relationship between SMI and medical/surgical readmissions. We compared demographic and clinical characteristics of patients with and without a comorbid SMI diagnosis. We divided the cohort into medical and surgical cohorts and studied the patients who had 30-day readmission separately. We examined the top 15 primary diagnoses for medical and surgical index admissions and readmissions. Finally, we examined the impact of a comorbid SMI diagnosis on 30-day readmissions for medical and surgical hospitalizations using unadjusted and adjusted logistic regression models.
METHOD

Data and study sample classification
To accomplish our aims, we used data from two sources. For Aim 1, we used the California Patient Discharge Data for years 2010 through 2014 [32] , and for Aim 2, we used the National Readmission Database (NRD) for 2014 [33] . The study sample included all patients who had a hospital inpatient stay and were discharged alive from California with an initial diagnosis of AMI, CHF, or Pneumonia. We focused on these three index conditions when we examined index and non-index hospital readmissions. We limited the scope of discharge date between February 1, 2010 and November 30, 2014 to capture any potential readmission within 30 days of an index discharge. We excluded patients who: did not reside in California, left against medical advice or transferred to another acute hospital, died during their inpatient stay, were transferred to another hospital within in a day, and were admitted with a primary diagnosis of mental diseases and disorders (i.e. MDC 19).
Aim 1 California dataset
Aim 2 NRD dataset
The National Readmission Database (NRD) is sponsored by the Agency for Healthcare For Aim 2, we identified medical and surgical readmissions based on the methodology provided by HCUP [34] . We excluded hospitalization designated as "planned" readmissions (obstetrics/pregnancy, chemotherapy, transplant procedures), patients admitted with a primary psychiatric diagnosis, those admitted for a primary or secondary diagnosis of dementia, those under the age of 18 or over the age of 100, those who died in the hospital, patients with less than 24 hours' stay in the hospital, those who transferred to another hospital, and those who left against medical advice because clinically they would be difficult to engage in future intervention strategies aimed at reducing readmissions. For patients with multiple readmissions within 30 days, we only include the first readmission.
Outcome measure and explanatory variables
Aim 1: CHF/AMI/pneumonia readmissions
The main outcome measure for Aim 1 was CHF, AMI and pneumonia patients' differenthospital readmission. and the trends of non-index readmission for these three diagnoses.
We classified readmissions into indexed and non-index based on whether the patient got readmitted to the same hospital from where he/she was discharged.
Aim 2: National readmissions with comorbid SMI
The main outcome measure for Aim 2 was all-cause 30 readmissions. Covariates were selected based on a review of existing studies on rehospitalization for the cohort of patients with mental illness [28] . Variables were constructed into three sets: patient demographics, clinical, and hospital characteristics. For patient demographics, age, gender, primary insurance (i.e. Medicare, Medicaid, Private, other), location (urban, metropolitan, micro metropolitan, or rural), and income level (i.e. $1-39,999, $40,000-50,999, $51,000-65,999, >=$66,000) were considered. Hospital characteristics were the number of beds, hospital location (urban, metropolitan, micro metropolitan, or rural), teaching status, and ownership (government, non-profit private, or investor-owned). Clinical characteristics included the number of Elixhauser comorbidities.
ANALYSIS
Aim 1 Analysis: California CHF/AMI/pneumonia readmissions
The main aim is to detect the relationship between multiple predictors and the differenthospital readmission. We constructed the data structure based on the data we prepared. We identified the admissions which were followed by a readmission within 7, 10, 15, 20, 25, 30 days. Then, we identified three cohorts of patients with admissions for: CHF (MSDRGs 291 to 293), AMI (MSDRGs 280 to 285) and Pneumonia (MSDRGs 193 to 195) . For each of the diagnosis cohorts, we divided them into Medicare and non-Medicare group, and identified those who had readmitted to hospitals other than those they were discharged from (i.e. "different-hospitals").
Prior to the main analysis, some preliminary analysis was conducted. investor or public), number of beds, and teaching status. We examined the interaction between the age group and the readmission time window. Adjusted odds ratios and 95% confidence intervals were calculated for each of the explanatory variables to explain their association with the predictive outcome of non-index re-hospitalization. Additionally, zstatistics and associated p-values were used to determine whether the predictor variables were significantly associated with the readmission outcome to a non-index hospital.
Analysis were implemented in R-studio (version1.1.419) [35] and StataSE 14 [36] . where all the statistical tests were two-tailed and performed at the 0.05 level of significance.
Aim 2 analysis: national readmissions with comorbid SMI
The primary aim of this study is to examine the association between comorbid SMI and the readmission. The Federal Register defines SMI as a significant and chronic impairment in major domains resulting in persistent problems with cognition, mood, and life functioning [37] . As such, this study operationally defined SMI to encompass comorbid diagnoses of schizophrenia, bipolar disorder, and major depression. This definition of SMI has also been used in other studies examining SMI and subsequent medical readmissions [28, 38, 39] .
Before performing our aim analysis to examining the association of comorbid SMI with readmissions, we did some preliminary studies. Descriptive statistics were calculated for all of the study variables characteristics of patients and hospital. Each characteristic was compared among patients with SMI and those without SMI using F-test for continuous variables (age, length of stay, number of medical/surgical admissions) and chi-square test for categorical variables (age group, gender, primary insurance categories (i.e. Medicare, Medicaid, Private, other), patient location (i.e. urban, small metropolitan, micro metropolitan, rural area), median household income quartile (i.e. $1-39,999, $40,000-50,999, $51,000-65,999, >=$66,000), hospital size (i.e. small, medium, large), hospital location (i.e. urban, small metropolitan, micro metropolitan, rural area), teaching status A decreasing rate of readmission to non-index hospitals was also observed with longer readmission intervals among CHF patients without Medicare (Figure 8 ). In Figure 9 , we showed the rate of readmission to a different hospital decreased with longer readmission intervals 2011 and 2013 for Medicare patients with AMI ( Figure 9 ). Though, in 2012 and 2014 this decreasing trend is not that prominent, rather an increase in the percentage is found beyond 20-day readmission window. In Figure 10 , a decreasing trend of readmission to a different hospital with longer readmission intervals was observed among AMI patients without Medicare (Figure10). In Figure 12 , we show the similar decreasing trend of nonindex readmission rate with readmission interval was also observed for non-Medicare patients with pneumonia in all but 2011 where an increasing trend is observed (Figure 12 ).
However, the tendency of Medicare counterpart of pneumonia patients being readmitted to different hospitals stays nearly same with the change of readmission interval ( Figure 11 ). Table 4 describes demographic, clinical and hospital characteristics of the sample for patients with and without a comorbid SMI diagnosis for medical/surgical index admissions. failure (p-value < 0.001), pneumonia (p-value < 0.001) and COPD (p-value < 0.001) had significant differences between index admissions and readmissions. Table 8 and Table 9 p-value < 0.001) patients with SMI had higher rates of 30 day readmissions compared to those without SMI. As also shown in Table 11 , among surgical patients, those with comorbid SMI had higher readmission rates than patients without SMI across all diagnoses (19.31% versus 9.35%; p-value < 0.001). The readmission rates of patients with a compared to those without a comorbid SMI diagnosis. The percentages represent the proportion of patients with/without SMI who are rehospitalized within 30 days. Table 12 shows the unadjusted odds ratios for the impact of SMI status on odds of medical and surgical 30-day readmissions. We found that compared to patients without SMI, those with SMI had 1.86 (CHF) to 2.74 (hip replacement) greater odds of 30-day readmission.
Aim 2: Analysis of national readmissions with comorbid SMI
Patients with SMI in surgical group had an even higher odds ratio than those whose index admissions were medical. Table 13 shows adjusted odds ratios and 95% confidence intervals of the impact of SMI status on 30-day readmissions for medical patients. Table 17 index hospitals in a significant rate may necessitate additional care to improve overall hospital service quality. A consistent decreasing trend of non-index readmission rate with length of readmission interval was observed among non-Medicare patients for all of CHF, AMI and pneumonia cohorts, which may suggest the early readmission interval is critical.
We identified several significant predictors for CHF, AMI and pneumonia patients' 30-day non-index hospital readmission. For all three conditions, male was positively associated with the prediction of non-index hospital readmission. Admission through the emergency department was associated with lower odds of changing hospital during readmission for AMI cohort, whereas it was insignificant for CHF and pneumonia. On the other hand, going for readmission for same primary diagnosis as at index admission reduced risk of changing hospital during the readmission for CHF and pneumonia cohort, but not for AMI cohort.
Charlson comorbid index had a negative association with CHF and AMI non-index hospital readmission, but not with pneumonia cohort. The index hospital owned by investor may significantly increase the risk of discharged patients changing hospital in their readmissions for all of three conditions. The result also shows a larger index hospital can decrease the odds of changing hospital during readmission. For CHF cohort, the index discharge happened in 2013 and 2014 had a higher odds of changing hospital, which indicates there was some effect of the penalty policy implemented in October 2012 influenced the strategy of hospital regarding CHF patients. However, this phenomenon was not observed in AMI and pneumonia cohort.
The higher 30-day non-index rehospitalization rate that we observed for non-Medicare patients as compared to Medicare patients has important policy implications for measuring, reporting, and the 30-day readmission rate. Also, we recommend attention to non-Medicare beneficiary care quality to improve the overall service quality of the hospitals, which has not received significant attention in the ongoing state-of-of-the-art research. Our predictive models identified the impacts of patients' socio-demographic and clinical factors on the non-index hospital readmission among Medicare and non-Medicare group. Therefore, we suggest the policy maker consider more thoroughly as making flexible strategies to improve care quality for different conditions.
In Aim 2, we found that a comorbid SMI diagnosis was associated with increased odds of 30-day rehospitalization among both medical and surgical inpatients, even after we controlled demographic, clinical and hospital charactersitics. The findings support most of previous studies [5, 22, 38, 44] for medical cohort, but conflict with previous literatures which claimed that there was no significant association between comorbid SMI and rehospitalization for surgical inpatients [28, 45] . The high odds of 30-day rehospitalization among medical and surgical patients can be explained by a poor quality health care due to limited access to transitional support postdischarge, community-based care options, and integrated health and behavioral health care [46, 47] . Our study suggests patients with comorbid SMI should be considered at high risk for readmission for both medical and surgical groups. Targeting interventions to these patients may be effective in preventing avoidable readmissions.
Limitations
Our studies were not without limitations. For Aim 1, which used California Patient Discharge Data, although the sample was large, it cannot be generalized to patients and hospitals nationally. We used same study period for different readmission interval, we cannot track the 45-day and 60-day readmissions whose index admissions happened in February 2010 and October 2014, which may lead to underestimate of readmission rate for 45, 60-day readmission. For Aim 2, which used National Readmission Database, we did not include patients who could use hospital service outside, and therefore, the number of rehospitalizations might be undercounted. There might be some unobserved confounders.
Although we found a significant effect of comorbid SMI, we were unable to adjust for severity of SMI.
Future work
Given our findings, this area of research warrants further investigation. For Aim 1, we need to delve into our findings in multivariate analysis to full understand the deep reason behind the results. our predictive models for predicting non-index hospital readmission still had relatively low AUC index for CHF (0.618), AMI (0.626) and pneumonia (0.630). We need to modify our predictive models and improve the performance of predicting non-index hospital readmissions. So far we still have little understanding of consequence of non-index hospital readmission quantitatively, it is also necessary for us to determine the mortality or cost for non-index hospital in a quantitative level. For Aim 2, we need to find out the reasons of confliction between our findings and pervious findings on surgical patients' readmission. We only considered 30-day readmissions in this study, the readmissions on more readmission intervals would need to be examined. In addition, the impact of comorbid SMI diagnosis on readission cost also worth to be explored.
Conclusion
This study's findings report for the first time that non-Medicare patients have higher odds to be readmitted in a different hospital compared to Medicare patients. We also found both medical and surgical inpatients with a comorbid SMI diagnosis are associated with higher odds of readmission than those without a comorbid SMI diagnosis. The finding suggested greater attention is required to improve hospital care quality for non-Medicare patients and patients with comorbid SMI diagnosis.
